38 results about "Hospitalization cost" patented technology

The invention discloses a method, a mobile terminal and storage equipment using a social security card to realize treatment payment; the method comprises the following steps: a user internet online account is engaged with a user social security card in advance through online or offline real name authentication; when a medical institution supporting direct online payment of the social security card finishes user diagnosis and treatments, the mobile terminal receives that the user selects to use the social security user payment ID to pay, and the social security system uses a pre-settlement function to send the user consumption item information to the social security bureau settlement system for checking the medical insurance settlement proportions; the social security system automatically submits and derates outpatient expenditure and hospitalization costs in the reimbursement scope, and the residual costs are paid by using other modes. The method uses the social security card to serve as an innovation inlet engaging the internet medical treatments, directly use the social security card to register and get appointments, see a doctor, claim insurances, apply reimbursements and pay, thus realizing one-card-for-all in the medical field, and providing uniform convenient medical services for users.

The invention relates to a recombined fusion protein, in particular discloses a recombined long-acting glucagons peptide analogue and a preparation method thereof. The long-acting glucagons peptide analogue is polypeptide by directly connecting duodenin analogue exendin-4 and human serum albumin, and no connecting peptide exists between the exendin-4 and the human serum albumin. The long-acting glucagons peptide analogue greatly prolongs the half-life of the exendin-4 and is clinically used to reduce the frequency of injection administration, lighten the suffering of patients, improve the curative effect and decrease the hospitalization cost.

In allusion to the fact that currently patient who needs nebulizer therapy also needs oxygen therapy at the same time clinically, a more smooth oxygen conveying device needs to be rapidly used to carry out oxygen therapy after nebulization is finished, and frequent device replacement can apparently increase nursing burden and hospitalization costs. The device of driving liquid to be nebulized by gas can achieve complete and rapid switch between a nebulization state and an oxygen uptake state. A second air outlet is formed in the device, and a sealing part is arranged on the device. When the patient needs the oxygen therapy, sealing to the second air outlet is relieved by adjusting the sealing part, oxygen can go out smoothly, and the patient can receive the oxygen therapy. When the patient needs the nebulizer therapy, the second air outlet is sealed by adjusting the sealing part, liquid medicine in the device is nebulized, and the patient can receive the nebulizer therapy. The device of driving the liquid to be nebulized by the gas not only reduces workload of medical workers, but also meets requirements of safe and rapid switch between the nebulization state and the oxygen uptake state clinically.

The invention relates to a method for implanting and locating a micro planting nail for orthodontics. The method comprises the steps that an oral cavity to be implanted with the micro planting nail is subjected to CBCT (Cone Beam Computed Tomography); a three-dimensional reconstruction for an oral cavity structure is performed; a three-dimensional entity image model is formed; a micro planting nail model is imported into a computer; a preset planting position for the micro planting nail is determined; an occlusal plane plate is put in a mouth of a patient; a horizontal movable unit is arranged on the occlusal plane plate; a lifting and rotation unit connected with a planting gun guide tube is arranged on the movable unit; a vertical distance between the planting gun guide tube and the occlusal plane plate and a planting direction of the micro planting nail are determined; and a planting gun is finally connected with the planting gun guide tube for planting operation. The method has the benefits that the implantation precision of the micro planting nail can be improved effectively; an implantation falling-off rate of the micro planting nail is reduced; a good correction effect is achieved; the pain and the hospitalization cost of a patient can be relieved and reduced; and the clinical working time of a doctor is saved.

The invention discloses a telemedicine service system, which comprises a central service station and a remote emergency subsystem. The remote emergency subsystem is connected with the central service station through a wireless network, urgently calls the central service station when emergency cases occur, and builds video connection between the remote emergency subsystem and the central service station. According to the telemedicine service system, a novel interaction mode between medical experts and patients is established, the patients can receive consultations from experts in remote places, no matter in local areas, local hospitals or even at home, hospitalization cost is greatly reduced, treatment time is shortened, and medical treatment level in remote rural areas is improved.

The present invention provides a set of internal fixing surgical instruments for minimally invasive lumbosacral anterior fusion operation, including a series of components of a positioning channel, a guide pin, a main channel, a drilling head, an intervertebral processor with a self-adjusting rotary cutter head, a water-injection style intervertebral cleaner, a thick wall channel sleeve, a fixing channel, a fixing screw, a screw fastening device, a screw end cap, an end cap fastening device etc.; in view of the abnormal function of the intervertebral structure, intervertebral instability, nerve root involvement and other lesions of the lumber vertebra section caused by lumbar intervertebral DDD, the application of the instruments can reduce the injuries and damages to the adjacent soft tissues and the spine stable structure to the maximum extend based on the smooth completion of the surgical operations of disc excision, intervertebral space processing, intervertebral space expansion, intervertebral fusion, internal fixation and so on, at the same time, the present invention can also reduce the postoperative complications, shorten the hospital stay and reduce the hospitalization cost to the maximum extend, thereby improving the operation effects and the satisfaction to the maximum extend.

The invention discloses a hospitalization cost mining method and device. The method comprises the steps that original hospitalization cost data of a disease is pre-processed to acquire sample data; the sample data is partitioned into equal-number sample sections with a preset number according to a preset cluster number and hospitalization all-in cost, and the hospitalization cost divisor average value of the equal-number sample sections is adopted as an initial cluster core; the equal-number sample sections are clustered according to the proximity clustering rule, and the cluster core is recalculated; whether the recalculated cluster core meets the convergence conditions or not is judged, if yes, the next step is carried out, and if not, the initial cluster core is updated; the all-in cost in the sample sections is calculated, and cost divisors with the proportion larger than a preset value in the sample section with the maximum all-in cost is inquired. Based on the K-means clustering analysis method, the key factors influencing hospitalization all-in cost are mined from the mass hospitalization cost data, and a hospital can reasonably price the hospitalization cost.

The invention provides a blood vessel implant with a super hydrophobic and oleophobic compound nanometer coating. The blood vessel implant comprises all implant surfaces in contact with blood such as the inner and outer surfaces of a blood vessel catheter and the inner and outer surfaces of a blood vessel substitution (artificial blood vessel), the inner and outer surfaces of a blood vessel support are coated with nanometer coatings of super hydrophobic and oleophobic coatings. The blood vessel implant with the super hydrophobic and oleophobic compound nanometer coating has the advantages that all the implant surfaces in contact with the blood have a layer of protective film formed by fluorine-containing nano-polymers, the fluorine-containing nano-polymers have good super hydrophobicity and lipophobicity, the film isolates blood and the implant surfaces, the blood and implants are prevented from direct contact, the implants are prevented from promoting a blood clotting response in the blood, and blood coagulation is prevented; meanwhile, field planting of bacteria and fungi is prevented on the implant surfaces, and infection of bacteria and fungi is prevented; at the same time, the service life of the implants is prolonged, the pain of a patient is relived, the hospitalization time is shortened, and the hospitalization cost is saved.

The invention discloses an intelligent fee control system for a hospital, and the system comprises a client which comprises a passive fee control subsystem and an active fee control subsystem. According to the system, the hospitalization cost of each patient is automatically and transversely compared in an innovative and intelligent manner. The medical care personnel can analyze whether the charging of various items is reasonable in real time; the method for reducing the cost of the patient can be quickly and correctly found. By establishing the system, the fatigue of manual statistical analysis of clinical medical care is greatly relieved. The working efficiency is greatly improved. The patients can actively and actively participate in medical insurance fee control. Due to the establishment of the system, medical care personnel can consciously and actively control medical insurance expenses, expenses of some department patients with serious medical insurance exceeding standards are obviously reduced, the reduction amplitude has stability and sustainability, the medical expense of the medical insurance patients is better reduced, the medical service quality is improved, and due contributions are made for perfecting a modern hospital management system.

The invention discloses an application of statin medicines in preparing medicines used for treating chronic subdural hematoma (CSDH). The application provided by the invention has the advantages that: 1, the safety is high; the medicine does not cause severe complications; CSDH reoccurrence is prevented for a long time after applciation; and an effect is reliable; 2, medication is convenient and is easy to be accepted by patients, wherein the medicine needs to be taken only once a day, and an amount is appropriate, such that patient daily lives are not affected; 3, the medicine is economical, wherein the medicine can be orally taken at home, such that hospitalization costs, surgical treatment costs, and care worker costs before and after surgery are avoided; and 4, defects such as anesthesia risk, pain risk, surgical bleeding, brain physiological cycle disruption, brain function damage, postoperative infection and recurrence, and the like of a traditional borehole drainage operation used for treating CSDH are avoided.

The invention discloses a gene capable of determining the sensitivity of tumour cells to chemotherapy drugs, which is named TJP1 or ZO-1. The invention also discloses a method for predicting the chemotherapeutic effect on tumour by using the gene, and patients in which TJP1exrpression exists are sensitive to the chemotherapy drugs; and the patients suffering the loss of expression of TJP1 are endowed with tolerance to the chemotherapy drugs. The invention also discloses a method for improving the chemotherapeutic effect by improving or inducing TJP1 expression as well as the application of the gene to the prediction of chemotherapeutic effect on tumour, the increasing of tumour chemotherapy sensitivity and the preparation of oncotherapy drugs. The invention can be beneficial to the development of a TJP1 / ZO-1 expression related diagnostic reagent kit so as to predict the chemotherapeutic effect on patients, and also beneficial to the screening of anticarcinogen so as to find out chemical and biological molecules inducing the TJP1 / ZO-1 expression, thereby finally achieving the purposes of reducing the times of chemotherapy, increasing the recovery rate, alleviating the toxic side effects of the chemotherapy drugs, saving the hospitalization costs and generating outstanding economic and social benefits.

The invention provides a hospitalization expense medical insurance expenditure checking system and method. The hospitalization expense medical insurance expenditure checking method comprises the following steps: obtaining medicine actual purchase-sale-stock information of a to-be-audited hospital, electronic medical record information of hospitalization people and use record information of diagnosis and treatment equipment in an audit time period, analyzing the electronic medical record information of the hospitalization people; according to the electronic medical record information, carryingout statistics on medicine use information and inspection item information of the hospitalization hospital in the audit time period, and determining whether the medical insurance expenditure of the hospital is reasonable or not by checking whether the medicine use information of the hospital to be audited is consistent with the actual medicine purchase-sale-stock information and whether the inspection item information is consistent with the use record information of the diagnosis and treatment equipment or not in the auditing time period. By implementing the invention, whether the expenditureof the traditional Chinese medicine insurance of the hospitalization cost is reasonable can be automatically checked.

The invention discloses a fusion protein used for rapidly detecting type I diabetes. The fusion protein is a fusion protein ICA-GAD obtained by performing fusion expression on islet cell autoantigen (ICA69) and glutamate decarboxylase (GAD2) genes. The method disclosed by the invention comprises the following steps: performing B cell antigenic epitope analysis on the islet cell autoantigen (ICA69) and glutamate decarboxylase (GAD2) genes through DNA star software, determining the gene sequence, artificially synthesizing target genes (ICA-GAD), inserting the target genes into a protein expression vector pet28a, transforming into BL21(DE3) host bacteria, and adding IPTG to perform inducible expression on a target protein; purifying and separating the expression protein by using a Ni column and a dialysis bag; detecting the activity of the ICA-GAD fusion protein. According to the fusion protein disclosed by the invention, any one or two in antibodies can be detected at a time, the diagnostic efficiency of the type I diabetes is obviously improved, the detection time is shortened, and the hospitalization costs can be reduced.

The present application discloses a method for judging abnormal hospitalization behavior and related products. The method is applied to electronic equipment. The method includes: obtaining hospitalization data of insured persons from a medical database of a medical institution; extracting various expense information in the hospitalization data, the various expense information including drug expense, operation expense, postoperative reexamination expense, preoperative examination expense and total hospitalization expense; calculating a first ratio, a second ratio, a third ratio and a fourth ratio between the drug cost, the surgical cost, the postoperative reexamination cost, the preoperative examination cost and the total hospitalization cost, respectively; according to the first proportion, the second proportion, the third proportion and the fourth proportion, the judgment result of the insured person's hospitalization behavior is obtained, and the judgment result is sent to the terminal equipment of the medical institution to display the judgment result on the display interface of the terminal equipment of the medical institution. The embodiment of that present application is advantageous in solving the probability of arbitrage medical insurance funds to purchase medicines.

The system includes monitor for patients condition, CCD camera, image processing and recognition system, wireless transmitter, and computer management system for sickrooms. Images on the monitor picked up by CCD camera and through USB are transferred to image process and recognition system, which through RS232 is connected to wireless transmitter. The said wireless transmitter through GPRS / GSM switched in Internet system, which computer management system for sickrooms in guardianship center is connected to. The invention raises nursing quality for patients, lowers workload of medical care personnel and hospitalization costs.

The invention discloses a hospitalization expense prediction method and device based on artificial intelligence, and computer equipment, and relates to the technical field of artificial intelligence and digital medical treatment. The method comprises that: firstly, according to hospitalization medical data of existing regional hospitals, a hospitalization cost prediction model of the existing regional hospitals is obtained through training; and if the hospitalization medical data of the target hospital in the new region does not meet the data conditions which can be used for training to obtain a standard model, transfer learning processing is performed based on the hospitalization cost prediction model of the existing region hospital to obtain the hospitalization cost prediction model of the target hospital in the new region, and then the hospitalization cost required by hospitalization treatment of the target user in the new regional target hospital is predicted. According to the invention, the hospitalization cost prediction accuracy of the hospital can be improved under the condition that the hospital medical data is limited. In addition, the invention also relates to a block chain technology, and hospitalization medical data can be stored in a block chain to ensure data privacy and security.

The invention discloses an abnormal hospitalization behavior judgment method and a related product, the method is applied to electronic equipment, and the method comprises the following steps: obtaining historical hospitalization data of an insured person from a medical database of any medical institution; extracting various expenses in the historical hospitalization data, wherein the various expenses comprise medical expenses, surgical expenses, postoperative reexamination expenses, preoperative examination expenses and total hospitalization expenses; respectively calculating the proportionsof the medical cost, the surgical cost, the postoperative reexamination cost, the preoperative examination cost and the total hospitalization cost; and determining a determination result for the hospitalization behavior of the insured person according to the ratio of the preoperative examination cost to the total hospitalization cost, the ratio of the medical cost to the total hospitalization cost, the ratio of the surgical cost to the total hospitalization cost, and the relation of the ratio of the postoperative reexamination cost to the total hospitalization cost. According to the embodimentof the invention, the probability of extracting the medical insurance fund is reduced.

The invention provides a traditional Chinese medicine composition for curing chronic nasosinusitis, which includes a drug for oral administration and a drug for external use. Bulk drugs of the drug for oral administration include platycodon grandiflorum, radices ligustici sinensis, cocklebur fruit, flower bud of lily magnolia, centipeda minima, bunge cherry seeds, semen brassicae, roots of kudzu vine, Chinese honeylocust, gallnut, rhizoma atractylodis, liquorice, liquorice, codonopsis pilosula, pollen typhae, spina gleditsiae, Chinese yam, frankincense, rheum officinale, angelica sinensis, edible tulip, bulbus fritillariae cirrhosae, cortex acanthopanacis, leonurus and radix polygonati officinalis; and bulk drugs of the drug for external use include radix stemonae, scutellaria baicalensis, radices ligustici sinensis, cocklebur fruit, violet magnolia, centipeda minima, periostracum cicada, radices trichosanthis, caulis bambusae in taeniam, frankincense, liquorice, north artemisia anomala, cordate houttuynia, rhizoma phragmitis, agastache rugosus, garlic, verbena, leonurus and pollen typhae. The traditional Chinese medicine composition has high efficiency for curing chronic nasosinusitis, is quick to be effective, quickly alleviates pain of patients within a short time, has high cure rate, is low in recurrence rate, reduces hospitalization cost, enhances sterilization, reduces drug resistance, has no toxic and side effect, and avoids recurrence of illness.

The invention discloses a charge control method based on DRGs pre-grouping. The method comprises the following steps: 1) data integration: adopting a charge control system to obtain data from a hospital hospitalization clinical system; 2) predicting grouping through an in-hospital grouping device; 3) predicting the cost and the number of hospitalization days according to medical insurance historical settlement data; 4) obtaining DRG average charge and average hospitalization days of the first month region through a medical insurance calculation platform; 5) performing real-time early warning; 6) performing DRG balance statistical analysis; and (7) monitoring the charge control state, and monitoring the change trends of the average hospitalization cost increase, the medicine proportion, the actual compensation ratio and the self-charge item cost proportion each time. Based on the pre-grouping technology, the method is extended to the diagnosis and treatment process of doctors, the real-time performance is higher, the attending doctors can manually assign grouping and complete calculation of real-time cost and expense when having objection on prediction grouping, hospitalization expense and cost factors can be predicted in real time, and the method is used for hospitals to better adapt to the DRG medical insurance payment mode of grouping related to disease diagnosis.

The invention provides a naval hospital outpatient medical treatment system, which comprises: an arrival module, a pre-test triage module, a condition diagnosis module and a treatment module. By constructing a naval officer hospitalization cost and hospitalization day prediction model and a naval officer hospital outpatient medical treatment process optimized discrete event model, and implementingan intervention test, the invention proposes a personalized outpatient process optimization plan for different naval hospitals, and provides a reference for improving the efficiency of naval medicalresource allocation.

The invention discloses a medicine for curing malignant tumor. The medicine is prepared by using the following components according to the following proportions by weight: 8 to 12 parts of cat skull, 95 to 105 parts of oyster shell whiting, 18 to 22 parts of alum, 4 to 6 parts of musk, 8 to 12 parts of borneol, 4 to 6 parts of calomeas and 9 to 11 parts of minium. The medicine with a great power to kill malignant tumor cells is prepared by using the traditional Chinese medicines according to a formula. The medicine has a good effect in curing the malignant rumor ranging from phase I to phase IV, except blood cancer and bone cancer; the course of treatment is short; the cure rate is high; and the relapse rate is low. No operation is needed so that pains brought by the operation to a sufferer are avoided; no chemo-treatment, radiation treatment or other treatment is needed so that side effects brought by the chemo-treatment and the radiation treatment to the sufferer are avoided; no hospitalization is needed so that high hospitalization cost is avoided.

The invention relates to the field of medical appliances, in particular to a defecation nursing device for preventing perianal skin injury of a patient with severe diarrhea or fecal incontinence. The defecation nursing device comprises a defecation pipe and a defecation bag, the defecation pipe is provided with an air bag and an inflating pipe and is sleeved with a two-piece ostomy bag holder, the air bag is positioned 2-3 cm at the front end of the defecation pipe, the air bag is communicated with a one-way valve on the inflating pipe, the one-way valve is provided with an inflating hole, and the defecation pipe is communicated with the defecation bag. The defecation nursing device may also comprise an irrigating pipe, a hand-pressed air bag, and a bag body of the two-piece ostomy bag. The defecation nursing device of the invention may help a patient defecate, may bring greatly decreased occurrence of perianal skin injury, reduced nursing cost, relieved pain in the patient, shortened ICU (intensive care unit) hospital stay and reduced total hospitalization cost, and facilitates nursing work.

The invention discloses a prone-operative-position mattress. The prone-operative-position mattress comprises a prone-position mattress body, a head cushion, a trunk cushion and lower-limb cushions. The head cushion is arranged on the prone-position mattress body, the prone-position mattress body and the lower-limb cushions are connected with the trunk cushion, lower-limb grooves are formed at joints of the trunk cushion and the lower-limb cushions respectively, and the whole prone-operative-position mattress is of a vertical centrosymmetric structure. By the prone-operative-position mattress, patients can keep their operative positions unchanged for a long time during operations, and standard arrangement of the operative positions of the patients during prone-position operations is realized; the standard arrangement is reasonably designed on the condition that features of the prone-position operations, genders, heights and weights of the patients and different pressure bearing capabilities of limbs are fully taken into consideration, so that the limbs of the patients are reasonably supported to disperse the pressure borne by the trunks and the limbs of the patients so as to protect the patients; workload and working difficulty of medical workers are lowered; operation time of the patients is indirectly shortened, complications during and after the operations are reduced, hospital stays are shortened, and hospitalization costs are reduced.

This patent discloses a nursing management method, in particular a systematic and streamlined perioperative nursing management method for pediatric patients. The method includes a nursing method before operation, a nursing method during operation and a nursing method after operation. For patients, only the systematic combination of these three nursing methods can enable patients to receive psychological care, admission guidance, discharge guidance, pre-operation guidance, intra-operative care, post-operative care guidance, anesthesia, etc. during surgical treatment in the hospital. Wake-up nursing, postoperative rehabilitation guidance, discharge health guidance and other nursing care; these nursing work is systematized, streamlined and standardized, and applied to clinical nursing work. The training period for clinical nurses is shortened, and it is easy for nurses at all levels to master and operate. Improve the satisfaction of hospitalized pediatric patients and their parents to the hospital, speed up the recovery of children's diseases, reduce the number of days of hospitalization, reduce the cost of hospitalization, speed up the turnover rate of hospital beds, and greatly improve the service quality of the hospital.

The invention provides an artificial intelligence intervention system and method for diabetes five carriages. According to a medical examination result, historical pharmaceutical and intervention behaviors and other data of a user, from the six aspects of daily life, nutrients, diet, drinking, exercise and blood glucose monitoring, one set of intelligent, scientific and normative rehabilitation intervention guiding scheme is formulated for the user, and a needle decrease and medicine decrease intervention guiding scheme is indirectly provided on the basis of the rehabilitation intervention guiding scheme. According to the method, on the basis of intelligent reminding, monitoring and evaluating, the problems that a diabetic is poor in autorhythmicity and a scientific intervention method islacked are solved; a plan is reminded to be executed regularly and intelligently in a timed mode, and the execution result is evaluated and sent to the user and a designated guardian in real time; onthe basis of big data analysis, the problems existing in the intervention process of the diabetic are told, the diabetic is helped and supervised by the guardians (parents and specialists and the like) for correct and scientific intervention of the diabetic, the drug dependence is abandoned step by step, the living quality is improved, and the hospitalization cost is lowered.

The invention discloses a medicine for curing malignant tumor. The medicine is prepared by using the following components according to the following proportions by weight: 8 to 12 parts of cat skull, 95 to 105 parts of oyster shell whiting, 18 to 22 parts of alum, 4 to 6 parts of musk, 8 to 12 parts of borneol, 4 to 6 parts of calomeas and 9 to 11 parts of minium. The medicine with a great power to kill malignant tumor cells is prepared by using the traditional Chinese medicines according to a formula. The medicine has a good effect in curing the malignant rumor ranging from phase I to phase IV, except blood cancer and bone cancer; the course of treatment is short; the cure rate is high; and the relapse rate is low. No operation is needed so that pains brought by the operation to a sufferer are avoided; no chemo-treatment, radiation treatment or other treatment is needed so that side effects brought by the chemo-treatment and the radiation treatment to the sufferer are avoided; no hospitalization is needed so that high hospitalization cost is avoided.

The invention discloses a disease risk regulation model establishment method. According to the method, for historical data of patients in a hospital or all hospitals in a region, accompanying complications of the patients during hospitalization, population characteristics of patient individuals, hospitalization state sources and the like are integrated into affecting variable factors of disease treatment, and statistic models are established according to the DRG type of a disease diagnosis related group and final treatment information of the patients respectively for performing numerical prediction and analysis on the death rate, the hospitalization period and the hospitalization medical cost of the hospital patients. According to a risk regulation model, the complications and other hospitalization information variables of the patients during hospitalization are innovatively utilized, a check and regression method in classical statistics is adopted, and modeling is carried out in combination with an LASSO method, so that over-fitting caused by too many variables is avoided, the death rate, the hospitalization period and the hospitalization cost of the patients are quantitatively predicted, and new means and way are created for medical analysis and hospital management.

The embodiment of the invention discloses a DRG or DIP settlement method and system for a daytime operation. The method comprises the steps that patient data of a patient to be settled is acquired, and the patient data comprises hospital exit and admission data, operation data, hospitalization cost data and outpatient service cost data; when the hospitalization of the patient to be settled is determined to be the daytime operation hospitalization according to the exit and admission data and the operation data, determining the total hospitalization cost and the hospitalization medical insurance reimbursement cost according to the hospitalization cost data, and determining the first medical insurance reimbursement cost and the second medical insurance reimbursement cost according to the outpatient cost data; according to the first medical insurance reimbursement expense and the second medical insurance reimbursement expense, obtaining a difference expense, according to the hospitalization total expense, the hospitalization medical insurance reimbursement expense and the difference expense, determining the self-payment of the patient, and taking the self-payment of the patient as a DRG or DIP settlement result of the daytime operation. According to the technical scheme provided by the embodiment of the invention, the effect of timely settlement of the DRG or DIP of the daytime operation is achieved.

The invention discloses a hospitalization data filling system. A background server is used for converting paper-edition hospitalization data into electronic-edition hospitalization data and generating a two-dimensional code; printing equipment is used for printing the two-dimensional code on the admission notice; a mobile phone mobile terminal of an inpatient or a family member of the inpatient scans the two-dimensional code and fills in the two-dimensional code, so that electronic-edition inpatient data which are filled in are sent to a PC terminal; the PC terminal is used for carrying out format check on the received electronic hospitalization data and sending the electronic hospitalization data back to the mobile phone mobile terminal for signature confirmation; and the electronic hospitalization data after signature confirmation is sent to a background server, and the electronic hospitalization data is stored in a storage unit. On the premise of meeting the normalized management requirements of hospital epidemic situations, the time for handling hospitalization and transfer procedures can be shortened, the hospitalization cost can be saved, the burden of patients can be relieved, and the medical quality and the service level can be improved.

The invention provides an osteoporosis patient management platform and an operating method thereof. For a doctor, the system is capable of giving advice about multi-stage diagnoses, transfer treatment, and group consultation in real time to assist the doctor in carrying tracking management on illness states of patients and carrying out warning timely; and doctors and hospitals from different countries or in different areas are able to carry out seamless real-time collaboration. Besides, with the platform, a patient is capable of obtaining information of basic knowledge of the illness, prevention of the illness, and the current healthy state of the patient, obtaining information of a diagnosis plan and a diagnosis stage for the own illness state as well as caring advice in real time, obtaining medication, further consultation, and auxiliary treatment plans timely, and carrying out progress tracking and real-time feeding back. Therefore, doctors and patients are able to carry out one-to-one, many-to-one, one-to-many diagnosis interactions; the doctors can obtain the illness state information of the patients in real time to manage the osteoporosis patients efficiently for long time and avoid or reduce occurrence of fractures of the patients; the academic levels of the doctors are improved; the living quality of the patients is enhanced; and thetotal expenditure of the national hospitalization costs is reduced.